Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Exscientia plc EXAI
$5.08
-$0.21 (-4.15%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
604341500.00000000
-
week52high
16.45
-
week52low
4.09
-
Revenue
32900000
-
P/E TTM
-4
-
Beta
0.00000000
-
EPS
-1.13000000
-
Last Dividend
0.00000000
-
Next Earnings Date
23 мар 2023 г. в 12:30
Описание компании
Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on small molecule drug candidates. Its platform enables to design candidate drug molecules, as well as to provide patients with drug therapies through AI guided assessment. The company was founded in 2012 and is headquartered in Oxford, the United Kingdom.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Exscientia plc (EXAI) Q3 2022 Earnings Call Transcript
Seeking Alpha
15 ноя 2022 г. в 13:09
Exscientia plc (NASDAQ:EXAI ) Q3 2022 Earnings Conference Call November 15, 2022 8:30 AM ET Company Participants Sara Sherman - Vice President-Investor Relations Andrew Hopkins - Chief Executive Officer & Executive Director Ben Taylor - Chief Financial Officer & Chief Strategy Officer Dave Hallett - Chief Operating Officer Mike Krams - Chief Quantitative Medicine Officer Garry Pairaudeau - Chief Technology Officer Conference Call Participants Michael Ryskin - Bank of America Operator Hello, everyone. My name is Brent and I will be your conference operator today.
Exscientia to Report Third Quarter 2022 Financial Results on November 15, 2022
Business Wire
08 ноя 2022 г. в 07:00
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2022, on Tuesday, November 15, 2022, before the open of U.S. markets.
Exscientia plc (EXAI) CEO Andrew Hopkins on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
18 авг 2022 г. в 13:14
Exscientia plc (NASDAQ:EXAI ) Q2 2022 Earnings Conference Call August 18, 2022 8:30 AM ET Company Participants Sara Sherman - VP, IR Andrew L. Hopkins - Founder and CEO Ben R.
Wall Street Analysts Think Exscientia PLC Sponsored ADR (EXAI) Could Surge 63%: Read This Before Placing a Bet
Zacks Investment Research
16 июн 2022 г. в 11:35
The average of price targets set by Wall Street analysts indicates a potential upside of 62.6% in Exscientia PLC Sponsored ADR (EXAI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Exscientia PLC Sponsored ADR (EXAI) Upgraded to Buy: Here's Why
Zacks Investment Research
30 мая 2022 г. в 13:33
Exscientia PLC Sponsored ADR (EXAI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).